These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2875479)

  • 1. Benzo-pyrones in the treatment of chronic schizophrenic diseases.
    Casley-Smith JR; Casley-Smith JR; Johnson AF; Weston FK
    Psychiatry Res; 1986 Jul; 18(3):267-73. PubMed ID: 2875479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
    Piller NB; Morgan RG; Casley-Smith JR
    Br J Plast Surg; 1988 Jan; 41(1):20-7. PubMed ID: 3278764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The behavior of blood clotting and its inhibitors under long term treatment with 5,6-benzo-alpha-pyrone (coumarin). Double blind study].
    Köstering H; Bandura B; Merten HA; Wieding JU
    Arzneimittelforschung; 1985; 35(8):1303-6. PubMed ID: 3907641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of sudden deafness of vascular etiology with venoruton].
    Madej S
    Otolaryngol Pol; 1989; 43(3):214-7. PubMed ID: 2695884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial.
    Zhang XY; Zhou DF; Cao LY; Wu GY
    Psychopharmacology (Berl); 2006 Sep; 188(1):12-7. PubMed ID: 16906395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroven in the treatment of chronic venous insufficiency.
    Pulvertaft TB
    Practitioner; 1979 Dec; 223(1338):838-41. PubMed ID: 396527
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, placebo-controlled double-blind study of venoruton in the treatment of chronic venous insufficiency. Importance of the selection of patients].
    Balmer A; Limoni C
    Vasa; 1980; 9(1):76-82. PubMed ID: 7368843
    [No Abstract]   [Full Text] [Related]  

  • 9. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
    Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
    Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
    Artaria LG
    Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind, cross-over trial of O-(beta-hydroxyethyl) rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
    Faga A
    Br J Plast Surg; 1988 Jul; 41(4):444-5. PubMed ID: 3395777
    [No Abstract]   [Full Text] [Related]  

  • 13. Benzopyrones in treatment of schizophrenia.
    Casley-Smith JR
    Lancet; 1983 Feb; 1(8321):421. PubMed ID: 6130413
    [No Abstract]   [Full Text] [Related]  

  • 14. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK.
    Pulvertaft TB
    Vasa; 1983; 12(4):373-6. PubMed ID: 6362258
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticatatonic effect of venoruton.
    Aley KO; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Venalot depot in episiotomy. A prospective, consecutive, double-blind study].
    Pedersen KO; Kristensen OK; Gram-Hansen J
    Ugeskr Laeger; 1982 Jan; 144(2):92-3. PubMed ID: 7043841
    [No Abstract]   [Full Text] [Related]  

  • 17. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind trial of carbamazepine in negative symptom schizophrenia.
    Nachshoni T; Levin Y; Levy A; Kritz A; Neumann M
    Biol Psychiatry; 1994 Jan; 35(1):22-6. PubMed ID: 7909450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the routine treatment of Graves' orbitopathy be efficiently supplemented by the administration of Venalot?
    Frank K; Ding G; Raue F; Ziegler R
    Dev Ophthalmol; 1989; 20():127-9. PubMed ID: 2687048
    [No Abstract]   [Full Text] [Related]  

  • 20. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA
    Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.